The COVID-19 pandemic has presented considerable challenges to global health services and dictates almost every aspect of medical practice and policy. The menopausal transition may have significant consequences for respiratory health as COVID 19 symptoms subsides, lung function testing should be done to assess the consequences of this virus on lung health especially in menopausal woman.

The study group will consist of (40) obese menopausal women whom were recently recovered from mild-moderate COVID 19 for one month. The control group will consist of (40) obese menopausal women; whom will not affected by COVID 19. Using incentive spirometer, we will measure forced vital capacity FVC, forced expiratory volume FEV, Tiffano index TI and peak expiratory force PEF in both groups.

Inclusion Criteria:

• Participants recovered from mild to moderated signs and symptoms of COVID- 19 after one month.
• Ability to perform pulmonary function tests correctly.
• COVID-19 was diagnosed by positive polymerase chain reaction (PCR) testing on nasopharyngeal swab, oxygen saturation was ranged between 92-96% during illness period.
• CT chest shows ground glass opacity.
• Their D-dimer was less than 0.5 μg/ml.
• Two successive negative PCR were before included in study.
• Participants were in home isolation during illness period.

Exclusion Criteria:

• Chronic respiratory disease.
• Chronic heart disease.
• Diabetes mellitus.
• Smoking.
• Centralized isolation.
• Severe COVID-19.

Female menopausal women only.

all women will be aged from 45 to 55 years old in menopause, their BMI will be from 30 to 34.9 kg/m2.